USE OF HIGHLY SELECTIVE BUTYRYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE AND DEMENTIAS

摘要

The present invention is based on the discovery that highly selective butyrylcholinesterase inhibitors are useful for the treatment or prevention of aging-related cognitive impairment and Alzheimer's disease. Acymererine is particularly preferred as the butyrylcholinesterase inhibitor. SHE